|
|
|
|
|
|
|
PMWC 2027 Program Is Live
|
PMWC 2027: The program is live. Explore 15 focused programs spanning next-generation therapeutics, AI and computational medicine, precision diagnostics, and integrated precision medicine. Co-hosted by Stanford, UCSF, and Yale, PMWC features leaders including David Baker, Emmanuelle Charpentier, Andrew Ng, Fei-Fei Li, and Mary-Claire King, January 27-29, 2027, at the Santa Clara Convention Center.
|
|
|
|
|
|
|
|
By Tom von Gunden, Chief Editor, Drug Delivery Leader
|
The Immunogenicity subteam within The Subcutaneous Consortium discusses the impact of immunogenicity in biotherapeutics product development. They consider degrees of desired or acceptable immunogenic response and report on efforts at industry harmonization of assays employed in preclinical and clinical modeling.
|
|
|
|
|
|
Oligonucleotide Delivery To Neuromuscular Targets
|
|
By Ranjan Batra, Ph.D., and Doug Kerr, Ph.D., Dyne Therapeutics
|
Emerging therapies are being designed to safely deliver oligonucleotides to disease-relevant tissues. Delivery is no longer a technical hurdle to overcome but a strategic lever.
|
|
|
|
|
|
|
|
|
|
Optimizing Drug Delivery Through Smarter Substance Utilization
|
|
Article | By Enda McKeon, Jon Best, and Jonathan Turkowski, AbbVie
|
Optimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.
|
|
|
|
|
|
A New Approach To Dual-Chamber Drug Delivery
|
|
Article | By Marc Flippe and Sophie Lelias, BD Medical - Pharmaceutical Systems
|
A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.
|
|
|
|
|
|
Expanding Opportunities For Inhaled Drug Delivery
|
|
Article | By Gunilla Petersson, Ph.D., Nanoform
|
Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
|
|
|
|
|
|
|
|
|
|
Ophthalmic Drug Delivery: Meeting Modern Challenges
|
|
Article | By Abigail Hisler, West Pharmaceutical Services, Inc.
|
Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
